BioStem Technologies (OTC: BSEM) Alternatives & Competitors

10 companies similar to BioStem Technologies (OTC: BSEM) — We Manufacture Products That Change Lives

Nordmark Pharma GmbH

Full Solution Partner für biopharmazeutische Wirkstoffe und Arzneimittel

264

Uetersen, Germany

Biotechnology Food and Beverage +2

Compare

Arcellx

Arcellx is a clinical-stage biotechnology company based in Redwood City, California

121 Acquired $8.43B

Redwood City, United Stat...

Biopharma Biotechnology +3

Compare

Aurora Pharmaceutical Inc

Value-added veterinary pharmaceuticals through innovative science and state-of-the-art tec...

78 Venture round $7.46M

Northfield, United States

Biotechnology Health Care +2

Core Biogenesis

The future of recombinant protein bioproduction for Regenerative Medicine & Skincare.

31 Seed $12.60M

Paris, France

Biotechnology Life Sciences +1

Rival Readout

Competing with BioStem Technologies (OTC: BSEM)? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

pixlbio

pixl x bio: from cells to pixels to predictions

21 Series A $11.53M

Uppsala, Sweden

Biotechnology Health Care +1

LUCA Science Inc.

Enabling functional mitochondria as therapeutic agents.

12 Series B $3.87B

Japan

Biotechnology Health Care +1

Targazyme

11 Series A $60.00M

Biopharma Biotechnology +2

Canvax

Powerful Solutions to Accelerate your Biologics Manufacturing.

12 Grant $50.00K

Spain

Biopharma Biotechnology +1

Regenosine

Harnessing the healing potential of adenosine for tissue regeneration

2 Grant $1.84M

Jersey City, United State...

Biotechnology Health Care +1

123Compliance Corporation

11-50 Debt Financing $450.00K

Analytics Biotechnology +2

About BioStem Technologies (OTC: BSEM)

BioStem Technologies (OTC: BSEM) is a leading innovator in the biotechnology and pharmaceutical industries, specializing in the development, manufacture, and commercialization of allografts for regenerative therapies. The company's BioRetain processing method is at the core of its focus on manufacturing products that c...

Business keywords

Regenerative Medicine, Perinatal Tissue, Allografts, BioRetain Processing, Growth Factors Preservation, Quality Management, AATB Accreditation, CGTP, CGMP, FDA Registered, VENDAJE, Placental Allograft

Frequently Asked Questions

Companies similar to BioStem Technologies (OTC: BSEM) include Nordmark Pharma GmbH, Arcellx, Aurora Pharmaceutical Inc, Core Biogenesis, pixlbio. They work in Biotechnology and Pharmaceutical and share BioStem Technologies (OTC: BSEM)'s focus on regenerative medicine, quality management and cgmp.

Bounce Watch lists 10 companies that share BioStem Technologies (OTC: BSEM)'s industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around BioStem Technologies (OTC: BSEM): 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

BioStem Technologies (OTC: BSEM) Profile Nordmark Pharma GmbH Alternatives Arcellx Alternatives Aurora Pharmaceutical Inc Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at BioStem Technologies (OTC: BSEM) on 12 Sep 2024. The 10 companies listed here were last checked between 12 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.